Glycosylated-imidazole aldoximes as reactivators of pesticides inhibited AChE : Synthesis and in-vitro reactivation study

Copyright © 2020 Elsevier B.V. All rights reserved..

The present armamentarium of commercially available antidotes provides limited protection against the neurological effects of organophosphate exposure. Hence, there is an urgent need to design and develop molecules that can protect and reactivate inhibited-AChE in the central nervous system. Some natural compounds like glucose and certain amino acids (glutamate, the anion of glutamic acid) can easily cross the blood brain barrier although they are highly polar. Glucose is mainly transported by systems like glucose transporter protein type 1 (GLUT1). For this reason, a series of non-quaternary and quaternary glycosylated imidazolium oximes with different alkane linkers have been designed and synthesized. These compounds were evaluated for their in-vitro reactivation ability against pesticide (paraoxon-ethyl and paraoxon-methyl) inhibited-AChE and compared with standards antidote AChE reactivators pralidoxime and obidoxime. Several physicochemical properties including acid dissociation constant (pKa), logP, logD, HBD and HBA, have also been assessed for reported compounds. Out of the synthesized compounds, three have exhibited comparable potency with a standard antidote (pralidoxime).

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:80

Enthalten in:

Environmental toxicology and pharmacology - 80(2020) vom: 01. Nov., Seite 103454

Sprache:

Englisch

Beteiligte Personen:

Sharma, Rahul [VerfasserIn]
Upadhyaya, Kapil [VerfasserIn]
Gupta, Bhanushree [VerfasserIn]
Ghosh, Kallol K [VerfasserIn]
Tripathi, Rama P [VerfasserIn]
Musilek, Kamil [VerfasserIn]
Kuca, Kamil [VerfasserIn]

Links:

Volltext

Themen:

Acetylcholinesterase
Cholinesterase Inhibitors
Cholinesterase Reactivators
EC 3.1.1.7
Glycosylated-imidazole aldoximes
Imidazoles
Journal Article
Oximes
Pesticides
Physico-chemical properties
Reactivation

Anmerkungen:

Date Completed 10.02.2021

Date Revised 10.02.2021

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.etap.2020.103454

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM312221614